Dianthus Therapeutics | MGTA - Vertriebs- Und Verwaltungskosten

Aktienkurs
77.86
Täglich Wechseln
-2.46 -3.06%
Monatlich
58.22%
Jährlich
265.03%
Q1 Prognose
75.51




Vertriebs- Und Verwaltungskosten Veränderung Datum
Akebia Therapeutics USD 25.74M 1.93M 2025-03
Alaunos Therapeutics USD 585K 260K 2025-09
Avita Medical AUD 19.03M 1.95M 2025-12
Celltrion KRW 249.98B 16.36B 2025-09
Cspc Pharmaceutical CNY 1.97B 404.66M 2025-09
Deva Holding AS TRY 462.26M 48.18M 2023-09
Dianthus Therapeutics USD 8.2M 669K 2025-09
Divis Laboratories Ltd INR 3.4B 10M 2025-06
IQVIA Holdings USD 468M 46M 2025-12
Kangmei Pharma CNY 274.41M 15.05M 2025-09
Knight Therapeutics CAD 25.48M 119K 2024-09
Laboratorios Farma EUR 35.32M 2.75M 2025-06
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 2.84M 4.19M 2025-12
Moderna USD 308M 40M 2025-12
Neuren Pharmaceuticals AUD 3.74M 2.5M 2025-12
Organigram Holdings CAD 8.86M 499K 2025-09
Organon & Co USD 399M 54M 2025-09
Ovoca Bio EUR 2.96M 8K 2022-06
Pharma Mar EUR 17.31M 3.6M 2025-12
Qiagen NV USD 153.88M 10.77M 2025-12
Revvity USD 251.73M 9.82M 2025-12
Sartorius EUR 218.7M 6.5M 2025-09
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
Tectonic Therapeutic USD 4.96M 190K 2025-09
Tilray USD 24.85M 1.7M 2025-09
Viatris USD 1.03B 144.1M 2025-12
Xeris Pharmaceuticals USD 46.46M 2.07M 2025-09
Zz Pientze Pharmaceu CNY 171.91M 343.2M 2025-09